Latest Breaking News On - Cereno scientific - Page 4 : comparemela.com

Cereno Scientific publishes an additional document in conjunction with admission to trading on Nasdaq First North Growth Market

Cereno Scientific publishes an additional document in conjunction with admission to trading on Nasdaq First North Growth Market
privataaffarer.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from privataaffarer.se Daily Mail and Mail on Sunday newspapers.

United statesVastra gotalands lanJonas fogelbergKendall squareUniversity of michiganCompany certified adviserCereno scientific incCereno scientificNasdaq first northNasdaq firstSwedish spotlight stock market

Cereno Scientific has received conditional approval for admission to trading on Nasdaq First North Growth Market

Cereno Scientific has received conditional approval for admission to trading on Nasdaq First North Growth Market
privataaffarer.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from privataaffarer.se Daily Mail and Mail on Sunday newspapers.

United statesVastra gotalands lanKendall squareJonas fogelbergSwedish companies registration officeUniversity of michiganCompany certified adviserCereno scientific incCereno scientificNasdaq firstNasdaq first northSpotlight stock marketSwedish companies registrationSwedish spotlight stock market

Cereno Scientific : to present preclinical data for candidate drug CS585 at EHA2023 Hybrid Congress – the premier medical congress for hematology

Cereno Scientific ,a company developing innovative treatments for common and rare cardiovascular disease, today announced that an abstract on preclinical drug candidate CS585 has been. | May 15, 2023

United statesHall goldmanJonas fogelbergMichael holinstatSylviane lambertInstitute of medicineEuropean hematology associationScientific program committeeUniversity of gothenburgUniversity of michiganUniversity of michigan medical schoolTranslational research at cerenoCereno scientificTranslational researchAndrew rickenbergMichigan medical school

Cereno Scientific : shares progress update in the Phase II study with drug candidate CS1 in the rare disease PAH

Cereno Scientific , a company developing innovative treatments for common and rare cardiovascular disease, today announced an updated progress report of the Phase II study in pulmonary. | May 12, 2023

Jonas fogelbergCereno scientificCereno scientific ab publ stock exchangePress releaseN crnob se0008241558

Cereno Scientific : to present at Aktiedagen in Gothenburg on May 15, 2023

Cereno Scientific , a company developing innovative treatments for common and rare cardiovascular disease, today announced that the company will present at the event Aktiedagen,. | May 12, 2023

Jonas fogelbergHotel gothia towersCereno scientificChief executive officerChief medical officerCereno scientific ab publ stock exchangePress releaseVent crnob se0008241558